Cleared Traditional

K896731 - OXYGEN CATHETERS (FDA 510(k) Clearance)

Class I Anesthesiology device.

K896731 · Unoplast A/S · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1990
Decision
120d
Days
Class 1
Risk

K896731 is an FDA 510(k) clearance for the OXYGEN CATHETERS. Classified as Catheter, Nasal, Oxygen (product code BZB), Class I - General Controls.

Submitted by Unoplast A/S (Denmark, DK). The FDA issued a Cleared decision on March 30, 1990 after a review of 120 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5350 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Unoplast A/S devices

Submission Details

510(k) Number K896731 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 30, 1989
Decision Date March 30, 1990
Days to Decision 120 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
19d faster than avg
Panel avg: 139d · This submission: 120d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code BZB Catheter, Nasal, Oxygen
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 868.5350
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.